Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| AgZen | 2026 | Series B | $10.0M | Somerville |
| BEIT Inc. | 2026 | Venture - Series Unknown | $3.5M | Kraków |
| Lucira Health | 2022 | Post-IPO Debt | $80.0M | Emeryville |
| Chroma Medicine | 2023 | Series B | $135.0M | Cambridge |
| Fulfil Solutions | 2023 | Series B | $60.0M | Mountain View |
| Aquafortus | 2023 | Series A | $17.0M | Mangere |
| Plenty | 2023 | Grant | $20.0M | South San Francisco |
| ENOUGH | 2024 | Series C | Undisclosed | Glasgow |
| Insight M | 2025 | Series E | $30.0M | Sunnyvale |
| AIM | 2025 | Venture - Series Unknown | $50.0M | Bellevue |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | AgZen | Series B | $10.0M | Somerville, United States |
| 52 | BEIT Inc. | Venture - Series Unknown | $3.5M | Kraków, Poland |
| 53 | Lucira Health | Post-IPO Debt | $80.0M | Emeryville, United States |
| 54 | Chroma Medicine | Series B | $135.0M | Cambridge, United States |
| 55 | Fulfil Solutions | Series B | $60.0M | Mountain View, United States |
| 56 | Aquafortus | Series A | $17.0M | Mangere, New Zealand |
| 57 | Plenty | Grant | $20.0M | South San Francisco, United States |
| 58 | ENOUGH | Series C | Undisclosed | Glasgow, United Kingdom |
| 59 | Insight M | Series E | $30.0M | Sunnyvale, United States |
| 60 | AIM | Venture - Series Unknown | $50.0M | Bellevue, United States |
AgZen develops pesticide sprays stick to plants which reduces pollution and helps farmers save.
Computational Drug Discovery for Small-Molecule Teams
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
Fulfil provides fully robotic automation for grocery and other retail e-commerce
Aquafortus is a non-thermal recovery and crystallization technology platform.
Plenty is a vertical farming company that brings fresh, pesticide-free produce to customers.
ENOUGH is a food ingredient company that specializes in using the natural process of fermentation.
Insight M develops aerial monitoring technology to detect aerial methane leaks for the energy industry.
Scalable earthmoving is not optional. It's required for our civilization to flourish.
A wastewater data platform delivering population-level health insights
Akido is a care delivery platform based in Los Angeles with the mission to ensure our most vulnerable communities thrive.
Zeno is developing next-generation radioisotope power systems that generate carbon-free, resilient power for decades.
AI that monitors countless surveillance feeds.
Alta Resource Technologies provides innovative solutions for efficient mineral separation and sourcing.
Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
Equilibrium Energy is a Climate Generation power company focused on the creation and proliferation of clean energy.
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
Slip Robotics is a loading and unloading of trucks firm that offers service supply chain and mobile robotics for logistics industries.
Raptor Maps provides performance intelligence solutions for solar asset management.
The Smart Market for Institutional Investors
Pickle Robot specializes in supplying AI-enabled robotic automation systems tailored for unloading trailers and containers.
SaaS Customer Service AI Platform
Pyka develops autonomous electric aircraft to transform agriculture and logistics with innovative technology.
Tidal Metals produces decarbonized magnesium metal from seawater and desalination waste to reduce salinity.
DCVC has invested in 285 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
DCVC's top investment sectors include Biotechnology, Artificial Intelligence (AI), Robotics, Software, Farming. The firm invests across 64 different industry categories.
Among tracked funding rounds, Chroma Medicine received $135.0M in a Series B round. DCVC's total known invested capital is $5.1B.
DCVC's average investment size is $30.2M across its portfolio of 285 companies.
Recent DCVC portfolio additions include AgZen, BEIT Inc., Lucira Health, Chroma Medicine, Fulfil Solutions. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors